207 results on '"Sgalla, Giacomo"'
Search Results
2. Case of a 33-Year-Old Woman With Hemoptysis and Migrant Nodular Cavitary Lesions
3. Promising advances in treatments for the management of idiopathic pulmonary fibrosis
4. Hospitalizations as Clinical Trials Endpoint in ILD: Are We There Yet?
5. Restless legs syndrome: A new comorbidity in idiopathic pulmonary fibrosis
6. Acute Respiratory Distress Syndrome and Lung Fibrosis Complicating Surgery in a Patient With Crohn’s Disease
7. An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis: a look towards 2023 and beyond
8. Drug-Induced Interstitial Lung Disease in a patient treated with a combination of palbociclib and fulvestrant
9. An up-to-date review of approved and emerging antibody therapies for idiopathic pulmonary fibrosis
10. Fibrotic Hypersensitivity Pneumonitis: Diagnosis and Management
11. X-ray Micro-Computed Tomography for Nondestructive Three-Dimensional (3D) X-ray Histology
12. A randomized trial of pamrevlumab in patients with COVID‐19 pneumonia
13. GATA1-defective immune-megakaryocytes as possible drivers of idiopathic pulmonary fibrosis
14. Challenges in the diagnosis of idiopathic pulmonary fibrosis: the importance of a multidisciplinary approach
15. Experimental autotaxin inhibitors for the treatment of idiopathic pulmonary fibrosis
16. Mediastinal lymph node enlargement in idiopathic pulmonary fibrosis: relationships with disease progression and pulmonary function trends
17. GATA1-defective immune-megakaryocytes as possible drivers of idiopathic pulmonary fibrosis
18. Pulmonary Fibrosis and the Many Faces of UIP
19. BI 1015550: an investigational phosphodiesterase 4B (PDE4B) inhibitor for lung function decline in idiopathic pulmonary fibrosis (IPF)
20. Contributors
21. Management of Idiopathic Pulmonary Fibrosis
22. Better to Be an Agnostic than a Believer (at Least in Pulmonary Fibrosis)
23. Reply to Huang and Wei, Kang et al., and Ehteshami-Afshar and Raj
24. COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis
25. Do Randomized Clinical Trials Always Provide Certain Results? The Case of Tralokinumab in Idiopathic Pulmonary Fibrosis
26. “Velcro-type” crackles predict specific radiologic features of fibrotic interstitial lung disease
27. Idiopathic pulmonary fibrosis: pathogenesis and management
28. Road Toward a New Model of Care for Idiopathic Pulmonary Fibrosis in the Lazio Region
29. GATA1-defective immune-megakaryocytes as possible drivers of idiopathic pulmonary fibrosis
30. The Shorter, the Better: Can We Improve Efficiency of Idiopathic Pulmonary Fibrosis Trials?
31. Drug-Induced Interstitial Lung Disease in a patient treated with a combination of palbociclib and fulvestrant.
32. The Shorter, the Better: Can We Improve Efficiency of IPF Trials?
33. Adjunctive corticosteroid treatment for organizing pneumonia in COVID-19 patients with persistent respiratory failure
34. Advances with pharmacotherapy for the treatment of interstitial lung disease
35. COVID-related fibrosis: Insights into potential drug targets
36. Telemedicine-enabled, Hotel-based Management of Patients with COVID-19: A Single-Center Feasibility Study
37. Idiopathic pulmonary fibrosis: Diagnosis, epidemiology and natural history
38. Pulmonary Fibrosis and the Many Faces of UIP
39. Residual respiratory impairment after COVID-19 pneumonia
40. Clinical trials in idiopathic pulmonary fibrosis: where we have been and where we are going
41. An updated safety review of the drug treatments for idiopathic pulmonary fibrosis
42. Emerging drugs for the treatment of idiopathic pulmonary fibrosis: 2020 phase II clinical trials
43. Residual Respiratory Impairment After COVID-19 Pneumonia
44. Phase three clinical trials in idiopathic pulmonary fibrosis
45. Home spirometry to assess efficacy of pirfenidone in progressive unclassifiable interstitial lung disease: better the devil you know than the devil you don’t
46. Progressive Fibrosing Interstitial Lung Disease. A Proposed Integrated Algorithm for Management
47. Early diagnosis of idiopathic pulmonary fibrosis: Closer to the goal?
48. Mediastinal lymph node enlargement in idiopathic pulmonary fibrosis: relationships with disease progression and pulmonary function trends
49. Use of digital auscultation in patients with ARDS: a correlation study with CT imaging
50. Methylprednisolone pulse therapy in Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.